American Statistical Association Offers One-Day Course For Clinical Trial Statisticians On The Analysis Of Censored Data The American Statistical Association (ASA) is sponsoring a one-day workshop on Friday, April 18, at ASA headquarters here for clinical trial statisticians who wish to analyze their data with the best available methods. The course will review some of the key developments in the analysis of censored event time data over the past three decades. Dr. Danyu Lin, the Dennis Gillings Distinguished Professor of Biostatistics at the University of North Carolina at Chapel Hill, will conduct the course.
Source: www.medicalnewstoday.comPhysical Activity Is Natural Pain Reliever For Arthritis It may seem counterintuitive to exercise when suffering with joint pain, but physical activity is actually a natural pain reliever for most people suffering from arthritis. A recent study published in Arthritis Care and Research journal concluded that regular exercise, specifically the Arthritis Foundation Exercise Program, is an effective course in significantly improving and managing arthritis pain. This is good news for the aging population of U.S.
Source: www.medicalnewstoday.comNeck Pain Patients Prefer Acupuncture To Injections For neck pain sufferers, acupuncture may be a better treatment option than spinal injections, according to a recent SpineUniverse survey. 43.6% of acupuncture patients were satisfied or even very satisfied with their treatment. Only 41.3% of injection therapy patients reported satisfaction with the treatment.
Source: www.medicalnewstoday.comNeuropathic Pain - NSL-043 Achieves Phase I Trial Success NeuroDiscovery Ltd (ASX: NDL), a specialty neuroscience services provider and drug development company, is pleased to announce the success of its Phase I clinical trial of NSL-043. This trial is the first of two Phase I trials, designed to test the safety and tolerability of an oral formulation of NSL-043. The second trial is ongoing, and both are being undertaken in collaboration with the Company's 50/50 partner, Sosei Group Corporation.
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 AM
